Edition:
United Kingdom

John Miller

RPT-Iron-infusion maker Vifor aims to pump up heart, kidney portfolio

10:16am GMT

ZURICH, Dec 4 Swiss iron infusion maker Vifor Pharma is hunting for drugs to bolster its kidney- and heart-disease portfolio, sees deal-free years as "failures" and has the financial muscle to stay independent, Chief Executive Stefan Schulze told Reuters.

WHO looks at possible 'e-vaccination certificates' for travel

03 Dec 2020

ZURICH/GENEVA The World Health Organization (WHO) does not recommend countries issuing "immunity passports" for those who have recovered from COVID-19, but is looking at prospects of deploying e-vaccination certificates like those it is developing with Estonia.

WHO praises 'phenomenal' promise of COVID vaccines

03 Dec 2020

GENEVA/ZURICH The promise of COVID-19 vaccines is "phenomenal" and "potentially game-changing", World Health Organization European director Hans Kluge said on Thursday, a day after Britain became the first Western country to approve a shot. | Video

RPT-UPDATE 1-Swiss doctors urge COVID vulnerable to declare end-of-life wishes in advance

22 Nov 2020

ZURICH, Nov 20 Swiss doctors have urged those vulnerable to COVID-19 complications to record their wishes for end-of-life care in advance to help ease pressure on intensive care units, drawing criticism from an advocacy group.

Swiss doctors urge COVID vulnerable to declare end-of-life wishes in advance

20 Nov 2020

ZURICH Swiss doctors have urged those vulnerable to COVID-19 complications to record their wishes for end-of-life care in advance to help ease pressure on intensive care units, drawing criticism from an advocacy group.

Swiss doctors urge COVID vulnerable to declare end-of-life wishes in advance

20 Nov 2020

ZURICH Swiss doctors have urged those vulnerable to COVID-19 complications to record their wishes for end-of-life care in advance to help ease pressure on intensive care units, drawing criticism from an advocacy group.

Roche's Actemra helps the sickest COVID-19 patients, study shows

19 Nov 2020

ZURICH Roche's Actemra helped the sickest COVID-19 patients in a 303-patient study, the trial's lead investigator said on Thursday, bolstering what has been mixed evidence that the arthritis drug can be repurposed to help in the pandemic.

Breakthrough COVID vaccine tech could help defeat other diseases

17 Nov 2020

ZURICH/FRANKFURT Breakthrough technology that transforms the body into a virus-zapping vaccine factory is poised to revolutionise the fight against COVID-19 but future pandemics and even cancer could be next, scientists say.

Breakthrough COVID vaccine tech could help defeat other diseases

16 Nov 2020

ZURICH/FRANKFURT Breakthrough technology that transforms the body into a virus-zapping vaccine factory is poised to revolutionise the fight against COVID-19 but future pandemics and even cancer could be next, scientists say. The initial success of so-called messenger ribonucleic acid (mRNA) vaccines in late-stage trials by Moderna as well as Pfizer and its German partner BioNTech is the first proof the concept works.

World News